University of Texas Health
Introduction
University Of Texas Health is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-institution"> [@selkoe2012]
<div class="infobox-header">University of Texas Health</div> [@jack2018]
<div class="infobox-image"></div> [@poewe2017]
<div class="infobox-data"> [@corriveau2016]
<div class="infobox-row"><strong>Location:</strong> Houston, Texas, USA</div> [@van2020]
<div class="infobox-row"><strong>Type:</strong> Academic Health Science Center</div> [@irwin2019]
<div class="infobox-row"><strong>Founded:</strong> 1969</div> [@sims2023]
<div class="infobox-row"><strong>Affiliation:</strong> University of Texas System</div>
<div class="infobox-row"><strong>Website:</strong> <a href="https://www.uth.edu" target="_blank">uth.edu</a></div>
</div>
</div>
Overview
Mermaid diagram (expand to render)
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic health science center dedicated to advancing health care through excellence in education, research, and patient care. As part of the University of Texas System, UTHealth combines the resources of six schools, numerous research centers, and clinical practices to create a powerhouse for biomedical innovation in Texas.
The institution is a major hub for neurodegenerative disease research, particularly in Alzheimer's disease, Parkinson's disease, and stroke-related cognitive impairment.
Schools and Components
McGovern Medical School
The largest medical school in Texas, with over 1,000 students and extensive research programs in neuroscience and neurology.
Pioneering research in health informatics, AI for medical imaging, and computational neuroscience.
UTHealth School of Public Health
Population health research including epidemiology of neurodegenerative diseases.
Cizik School of Nursing
Research on caregiving for patients with dementia and neurodegenerative conditions.
UTHealth School of Dentistry
Research on oral-systemic health connections relevant to neurodegeneration.
Neurodegenerative Disease Research Programs
Mitchell Center for Neurodegenerative Diseases
The flagship center for neurodegenerative disease research at UTHealth:
- Alzheimer's Disease Research: Comprehensive program including clinical trials, biomarker development, and basic science
- Parkinson's Disease Program: Movement disorder research, deep brain stimulation, and non-motor symptom studies
- Stroke and Vascular Cognitive Impairment: Understanding vascular contributions to dementia
- ALS Research: Clinical trials and biomarker studies
Center for Alzheimer's Care, Prevention, and Treatment
This center focuses on:
- Early detection and prevention strategies
- Lifestyle modification interventions
- Caregiver support programs
- Health disparities in Alzheimer's disease
Parkinson's Disease Research Center
Comprehensive program including:
- Motor and non-motor symptom management
- Deep brain stimulation programming
- Physical therapy and rehabilitation
- Genetic counseling
Notable Researchers
John H. Morrison, PhD
- Dean of the Graduate School of Biomedical Sciences (former)
- Distinguished neuroscientist specializing in Alzheimer's disease
- Key research: Synaptic changes in aging and Alzheimer's, estrogen effects on the brain
- Notable Publications:
- "Synaptic remodeling in the prefrontal [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus) during aging" (Journal of Comparative Neurology)
- Multiple studies on estrogen and neuroprotection
Other Key Researchers
- Sudha Seshadri, MD: Director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
- Claudia Perez-Tobin, MD: Movement disorders specialist
- Michele Y. Johnson, MD: Cognitive neurologist
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
Named after a San Antonio businessman and community leader, this institute is UTHealth's flagship program for Alzheimer's disease and related disorders:
- Comprehensive memory assessment clinics
- State-of-the-art neuroimaging
- Clinical trials for new therapeutics
- Caregiver support and education programs
- Research on health disparities in Alzheimer's disease
Research Facilities
Center for Biomedical Imaging
- 3T and 7T MRI scanners
- PET imaging for amyloid and [tau](/proteins/tau)
- Advanced image analysis pipelines
Human Genetics Core
- DNA banking and genetic counseling
- GWAS and sequencing studies
- Precision medicine approaches
Clinical Research Unit
- Inpatient and outpatient research facilities
- Clinical trials infrastructure
Disease Focus
| Disease | Research Focus |
|---------|---------------|
| Alzheimer's Disease | Biomarkers, clinical trials, synaptic mechanisms |
| Parkinson's Disease | Movement disorders, DBS, non-motor symptoms |
| Vascular Cognitive Impairment | Stroke, vascular dementia |
| ALS | Clinical trials, biomarkers |
| Frontotemporal Dementia | Language variants, behavior variants |
Clinical Services
Memory Disorders Clinic
Comprehensive diagnostic and treatment services for:
- Alzheimer's disease
- Mild cognitive impairment
- Vascular dementia
- Lewy body dementia
- Frontotemporal dementia
Movement Disorders Clinic
Expert care for:
- [Parkinson's disease](/diseases/parkinsons-disease) Essential tremor
- Dystonia
- Huntington's disease
ALS Clinic
Multidisciplinary care including:
- Neurology
- Pulmonology
- Nutrition
- Physical therapy
- Social work
Collaborations
UTHealth collaborates extensively with:
- Texas Medical Center (world's largest medical complex)
- Baylor College of Medicine
- MD Anderson Cancer Center
- Michael J. Fox Foundation
- National Institute on Aging
- Alzheimer's Association
Training Programs
UTHealth offers comprehensive training in neurodegenerative diseases:
- Neurology residency
- Movement disorders fellowship
- Cognitive neurology fellowship
- Postdoctoral research training
- Graduate programs in neuroscience
Recent Research Highlights
BIGFAST Trial: Investigating aggressive blood pressure control to prevent vascular cognitive impairment
ALIZE Study: Novel imaging biomarker for early Alzheimer's detection
Parkinson's Progression Markers Initiative (PPMI): Participation in this landmark PD study
Texas Alzheimer's Research and Care Consortium: Statewide collaboration for Alzheimer's researchBackground
The study of University Of Texas Health has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- Texas Medical Center
- John Morrison, MD
- McGovern Medical School
- Biomarkers of Alzheimer Disease
- [clinical-trials](/clinical-trials)
External Links
- [UTHealth](https://www.uth.edu)
- [Glenn Biggs Institute](https://www.biggsinstitute.org)
- [UTHealth Neurology](https://www.med.uth.edu/neurology)
- [Texas Alzheimer's Association](https://www.alz.org/texas)
References
Morrison JH, et al, "Neurobiological consequences of estrogen signaling in the aging female primate brain." Proceedings of the National Academy of Sciences (2008)
Selkoe DJ, "Resolving the debate on the role of soluble Aβ oligomers in Alzheimer's disease." Neuron (2012)
Jack CR Jr, et al, "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease." Alzheimer's & Dementia (2018)
Poewe W, et al, "Parkinson disease." Nature Reviews Disease Primers (2017)
Corriveau RA, et al, "The Science of Alzheimer's Disease." Alzheimer's & Dementia (2016)
van der Flier WM, Scheltens P, "Alzheimer's disease." Lancet Neurology (2020)
Irwin DJ, et al, "Evaluation of potential prodromal Alzheimer's disease in a cohort of Parkinson's disease." JAMA Neurology (2019)
Sims JR, et al, "Donanemab in Early Symptomatic Alzheimer Disease." JAMA (2023)